Chronic Myeloid Leukaemia
Patent oppositions filed in

Dasatinib is a tyrosine kinase receptor inhibitor used as a target therapy in chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia patients.

This drug is missing the following documents, can you help us by contributing something?

Patent Information

Information of patent applications filed at local or international levels, that are contributed by the users of PODB as being relevant to this medicine

Please note that PODB does not provide and guarantee the comprehensive patent landscape in all countries.

*For more knowledge of patent search, please refer to the tutorial Step 2: Patent Search & Analysis
*For more information of the patent landscape on medicines, please also refer to WHO patent landscape reports, UNITAID patent landscape reports, Medicines Patent Pool Patent Status Database

Patent Applications

The table includes information of patent applications as filed in different countries, that are contributed by PODB users as being seen as relevant to this medicine.

CountryFiling datePriority dateApplicantNational numberInternational numberStatusPatent typeMore info
India26-07-2006Bristol-Myers Squibb Holdings Ireland4309/DELNP/2006WO/2005/077945RejectedSalts and OthersView/Comment
India19-09-2001Bristol-Myers Squibb Company IN/PCT/2001/01138/MUM WO/2000/062778GrantedMoleculesView/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top


Information related to relevant oppositions from around the world.

Patent Oppositions

The table includes oppositions aimed at contesting patents covering this drug. Note that at the country level, several patent applications can cover the same drug.

Please pay attention not only to the patent opposition, but also to the patent application it relates to, see column "Related Patent Application". To better identify similarities, the column "Patent Type" indicates a general classification of the patent. Arguments used to contest a specific type of patent may apply for another that fits in the same category.

CountryDateWho FiledOpposition typeOpposition statusPatent typeRelated patent applicationMore info
India20-11-2013BDR Pharmaceuticals Ltd.Pre-GrantGrantedSalts and Others4309/DELNP/2006View/Comment
India06-01-2012Natco Pharma Ltd.Pre-GrantGrantedSalts and Others4309/DELNP/2006View/Comment
India15-01-2018Poonam SinghPre-GrantGrantedSalts and Others4309/DELNP/2006View/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top

Patent Office Decisions

This table showcases the final ruling of patent offices over cases where patents have been opposed.

To better identify the case, the number of the patent application is provided in the table below.

Decision typeCountryDatePatent officeRelated patent applicationMore info
RejectionIndia29-10-2013Rejection of Compulsory License Application to BDRIN/PCT/2001/01138/MUM (IN203937)View/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top